AstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trial - Reuters
AstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trial Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Tags
All Coverage
<a href="https://news.google.com/rss/articles/CBMi5AFBVV95cUxNLXdhaVRKY2VrQnZteVlCd1FjUnpyc2NpYUt5NG0wZERDU0ZraWU5blhMOXBrRWVZWU1vVUZTbE5XaTRpVFFpSEZNV3ZTaDlVTTdHTnkwY1dxcWx2bUpwU0xRS0E0MkNIVFVkYjA1d28zZGxJazh1OGtKTzJWeVE4TWFldTRKMS1FUzVnQ0J5QVpmTW5rQTVwWXREWkk2WkRDTjFOanI2eF9QQ0E0cWtER1Zxd3JHTDBOMkVkSXFQOThoMmlZTHd5Mi1HMWg2b3YtcHp0SVhORFl6b0EtZjZlNnhmaUY?oc=5" target="_blank">AstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trial</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
GSK scores regulatory wins for chronic hepatitis B drug, cancer therapy - Reuters
GSK scores regulatory wins for chronic hepatitis B drug, cancer therapy Reuters
August 24, 2026 at 07:11 AMRevolution's lifesaving pancreatic cancer drug wins speedy FDA approval - Reuters
Revolution's lifesaving pancreatic cancer drug wins speedy FDA approval Reuters
August 26, 2026 at 06:18 PMSuccess after a century of failures: Inside Moderna and Merck's cancer vaccine breakthrough - Reuters
Success after a century of failures: Inside Moderna and Merck's cancer vaccine breakthrough Reuters
August 28, 2026 at 11:32 AMUS FDA approves Roivant-Priovant's skin and muscle disease drug - Reuters
US FDA approves Roivant-Priovant's skin and muscle disease drug Reuters
August 27, 2026 at 10:42 PMBristol Myers ends blood cancer drug deal with cell therapy maker Cellares - Reuters
Bristol Myers ends blood cancer drug deal with cell therapy maker Cellares Reuters
August 25, 2026 at 06:00 PMUS FDA expands approval for J&J's drug for rare blood disorder - Reuters
US FDA expands approval for J&J's drug for rare blood disorder Reuters
August 24, 2026 at 10:49 PM